The American Thyroid Association (ATA) integrates molecular testing into its framework for managing patients with anaplastic thyroid carcinoma (ATC): Update on the 2021 ATA ATC guidelines

Cancer Cytopathol. 2022 Mar;130(3):174-180. doi: 10.1002/cncy.22519. Epub 2021 Oct 7.

¹ Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
² Massachusetts Eye & Ear Infirmary, Boston, Massachusetts.
³ Department of Pathology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
⁴ Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Keywords: BRAF; anaplastic thyroid carcinoma; cytology; diagnosis; targeted therapy.

MeSH terms